These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31923338)

  • 1. Results of the guideline-based treatment for pemphigus: a single-centre experience with 84 cases.
    Kakuta R; Kurihara Y; Yamagami J; Miyamoto J; Funakoshi T; Tanikawa A; Amagai M
    J Eur Acad Dermatol Venereol; 2020 Jun; 34(6):1324-1330. PubMed ID: 31923338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.
    Olszewska M; Kolacinska-Strasz Z; Sulej J; Labecka H; Cwikla J; Natorska U; Blaszczyk M
    Am J Clin Dermatol; 2007; 8(2):85-92. PubMed ID: 17428113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of pemphigus vulgaris. Experience with 48 patients seen over an 11-year period.
    Mourellou O; Chaidemenos GC; Koussidou T; Kapetis E
    Br J Dermatol; 1995 Jul; 133(1):83-7. PubMed ID: 7669646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance therapy with azathioprine prolonged duration of remission for pemphigus patients who received rituximab as first-line or add-on therapy.
    Cho YT; Huang YM; Wang LF; Chu CY
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 2):230-237. PubMed ID: 31103376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose oral prednisone vs. prednisone plus azathioprine for the treatment of oral pemphigus: a retrospective, bi-centre, comparative study.
    Chaidemenos G; Apalla Z; Koussidou T; Papagarifallou I; Ioannides D
    J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):206-10. PubMed ID: 20569289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect.
    Chen DM; Odueyungbo A; Csinady E; Gearhart L; Lehane P; Cheu M; Maho-Vaillant M; Prost-Squarcioni C; Hebert V; Houivet E; Calbo S; Caillot F; Golinski ML; Labeille B; Picard-Dahan C; Paul C; Richard MA; Bouaziz JD; Duvert-Lehembre S; Bernard P; Caux F; Alexandre M; Ingen-Housz-Oro S; Vabres P; Delaporte E; Quereux G; Dupuy A; Debarbieux S; Avenel-Audran M; D'Incan M; Bedane C; Bénéton N; Jullien D; Dupin N; Misery L; Machet L; Beylot-Barry M; Dereure O; Sassolas B; Benichou J; Musette P; Joly P;
    Br J Dermatol; 2020 May; 182(5):1111-1119. PubMed ID: 31487383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant rituximab therapy in pemphigus: a single-center experience of 18 cases.
    Baum S; Gilboa S; Greenberger S; Pavlotsky F; Trau H; Barzilai A
    J Dermatolog Treat; 2013 Dec; 24(6):427-30. PubMed ID: 23521340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the use of methotrexate as an alternate therapy for pemphigus vulgaris and pemphigus foliaceus.
    Kolla A; Shah P; Cymerman R; Fruchter R; Adotama P; Soter NA
    Dermatol Ther; 2022 Aug; 35(8):e15661. PubMed ID: 35734997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressants and prednisone in pemphigus vulgaris: therapeutic results obtained in 63 patients between 1961 and 1975.
    Lever WF; Schaumburg-Lever G
    Arch Dermatol; 1977 Sep; 113(9):1236-41. PubMed ID: 900969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate is effective in the treatment of pemphigus vulgaris.
    Enk AH; Knop J
    Arch Dermatol; 1999 Jan; 135(1):54-6. PubMed ID: 9923781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective analysis of a single-center clinical experience toward development of curative treatment of 123 pemphigus patients with a long-term follow-up: efficacy and safety of the multidrug protocol combining intravenous immunoglobulin with the cytotoxic immunosuppressor and mitochondrion-protecting drugs.
    Grando SA
    Int J Dermatol; 2019 Jan; 58(1):114-125. PubMed ID: 30047585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients.
    Kim MR; Kim HC; Kim SC
    Dermatology; 2011; 223(2):182-8. PubMed ID: 22025028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of pemphigus. Critical remarks based on 44 clinical cases].
    Smolle J
    Hautarzt; 1985 Feb; 36(2):96-102. PubMed ID: 2985524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid-pulse therapy in pemphigus vulgaris long term follow-up.
    Chryssomallis F; Dimitriades A; Chaidemenos GC; Panagiotides D; Karakatsanis G
    Int J Dermatol; 1995 Jun; 34(6):438-42. PubMed ID: 7657447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and prognosis of myasthenia gravis in older people.
    Evoli A; Batocchi AP; Minisci C; Di Schino C; Tonali P
    J Am Geriatr Soc; 2000 Nov; 48(11):1442-8. PubMed ID: 11083321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of pemphigus vulgaris by azathioprine and low doses of prednisone (Lever scheme)].
    Benoit Corven C; Carvalho P; Prost C; Verret JL; Saiag P; Noblesse I; Bedane C; Chosidow O; Young P; Roujeau JC; Joly P
    Ann Dermatol Venereol; 2003 Jan; 130(1 Pt 1):13-5. PubMed ID: 12605150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of cyclophosphamide in azathioprine failures in pemphigus.
    Ahmed AR; Hombal S
    J Am Acad Dermatol; 1987 Sep; 17(3):437-42. PubMed ID: 3655023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment outcomes in a cohort of patients with mucosal-predominant pemphigus vulgaris.
    Ojaimi S; O'Connor K; Lin MW; Schifter M; Fulcher DA
    Intern Med J; 2015 Mar; 45(3):284-92. PubMed ID: 25534017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of pemphigus vulgaris.
    Kavusi S; Daneshpazhooh M; Farahani F; Abedini R; Lajevardi V; Chams-Davatchi C
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):580-4. PubMed ID: 18194237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the adjuvant effect of tacrolimus in the management of pemphigus vulgaris: A randomized controlled trial.
    Dastgheib L; Sadati MS; Baghernejhad M
    J Dermatolog Treat; 2015 Feb; 26(1):90-3. PubMed ID: 24552352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.